Deadly Medicines and Organised Crime – How Big Pharma Has Corrupted Healthcare
It examines how clinical trials are undertaken – the apparent conflicts of interest, including prescribers receiving sponsorship from drug companies – the ways medicines are sold, and how drug companies are regulated. It then goes on to review specific drugs.
As a doctor, medical researcher, and former drug company representative who ‘sold’ drugs to other doctors, the author seems well placed to undertake this review, and he provides a wealth of evidence to support his position.
He argues powerfully for the need to reform the current system of drug research, trials and licensing. As well as pointing out the flaws in the current system, the author suggests reforms.
One important point to note – although the author sees the same characteristics in the drug industry and drug companies as can be seen in organised crime, this book does not actually examine or discuss organised crime.
Want to read more?
Unlock full access to RCNi Plus today
Save over 50% on your first three months:
- Customisable clinical dashboard featuring 200+ topics
- Unlimited online access to all 10 RCNi Journals including Nursing Standard
- RCNi Learning featuring 180+ RCN accredited learning modules
- NMC-compliant RCNi Portfolio to build evidence for revalidation
- Personalised newsletters tailored to your interests